There are 3397 resources available
Revisiting old friends: New clinical developments of MEKi/BRAFi/NRASi combinations
Presenter: Ryan Sullivan
Session: What’s the future in melanoma therapy? Novel targets, new drugs, reinvented approaches
Resources:
Slides
Webcast
How often and to which extent does the E-E gap seriously affect treatment outcome in daily practice?
Presenter: Gabe Sonke
Session: Bridging the Efficacy-Effectiveness (E-E) gap for cancer therapies
Resources:
Slides
Webcast
Duration of IO treatment
Presenter: Benjamin Besse
Session: Open questions in immunotherapy for advanced NSCLC: Duration of IO, combinations and rechallenge
Resources:
Slides
Webcast
Wearable medical devices in oncology: Hopes and hypes for patients and health professionals
Presenter: Henrique Martins
Session: Do we enter a new era of oncology with big data and artificial intelligence?
Resources:
Slides
Webcast
376O - Trastuzumab deruxtecan (T-DXd) versus treatment of physician’s choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Updated survival results of the randomized, phase III DESTINY-Breast04 study
Presenter: Shanu Modi
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
1206O - Clinical subtyping of cancer from blood based on comprehensive epigenomic profiling
Presenter: Sylvan Baca
Session: Proffered Paper session 1 - Basic Science and Translational research
Resources:
Abstract
Slides
Webcast
503MO - Real-world clinical and genomic characterization of gliomas: Predictive and prognostic insights
Presenter: Oriol Mirallas
Session: Mini oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
LBA46 - SAKK 11/16, a phase IIa trial evaluating overall survival (OS) for recurrent/metastatic Head & neck squamous cell carcinoma (RMHNSCC) patients (pts) progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy
Presenter: Nicolas Mach
Session: Mini oral session - Head and neck cancer
Resources:
Abstract
Slides
Webcast
Immunotherapy re-challenge: Who, when and why
Presenter: Natasha Leighl
Session: Open questions in immunotherapy for advanced NSCLC: Duration of IO, combinations and rechallenge
Resources:
Slides
Webcast
Invited Discussant 381O and 376O
Presenter: Giampaolo Bianchini
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Slides
Webcast